ArticleMedComm2026

Advocating for Precision Neoadjuvant and Subsequent Adjuvant Therapies in Esophageal Squamous Cell Carcinoma: Evidence From a Real-World Multicenter Study.

Peiyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.